<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336587">
  <stage>Registered</stage>
  <submitdate>24/02/2011</submitdate>
  <approvaldate>25/02/2011</approvaldate>
  <actrnumber>ACTRN12611000211965</actrnumber>
  <trial_identification>
    <studytitle>Determination of the digestive health benefits of new barley breakfast cereals.</studytitle>
    <scientifictitle>Determination of the digestive health benefits of new barley breakfast cereals in healthy male and female adults.</scientifictitle>
    <utrn>Nil</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Normal bowel health and function</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Normal oral and gastrointestinal development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>We will be testing 4 different breakfast cereals, a conventional barley cereal, 2 new barley cereals and a refined cereal. Barley cereals are derived from Barley lines that differ in nutrient composition. Participants will consume each of the 4 test foods in 4 week blocks, with each test food period to be separated by 2 weeks. For the duration of the study participants will be required to consume their usual diet with some restrictions to ensure it is low in fibre. For each 4 week test period, they will be required to consume 50g of the test food daily. At the beginning of the study and at the end of each 4 week testing period participants will be required to attend the Clinic for a 15 minute appointment to discuss digestive health and prior to the visit collect a 48 hour faecal and urine collection and 3 short questionnaires (product consumption checklist, 3-day food diary and physical activity questionnaire). At baseline only, they will be required to undergo a whole body and forearm DEXA scan.</interventions>
    <comparator>refined cereal</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
    <interventioncode>Lifestyle</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Bowel function:
participant self-report - bowel habits
laboratory analysis - faecal pH, fermentation profile</outcome>
      <timepoint>Baseline and after each 4 week test food period</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Digestive comfort questionnaire</outcome>
      <timepoint>Baseline and after each 4 week test food period</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Mineral balance: urine laboratory analysis</outcome>
      <timepoint>baseline and after each 4 week test food period</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Dual Energy Xray Absorptiometry scan for body composition and bone mineral density</outcome>
      <timepoint>baseline</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Male or female, aged 20-80 years.
BMI 19-25.
Not received any medication that in the opinion of the investigator could interfere with the study and no medications likely to modulate gut function.
No history of alcohol or drug abuse.
No participation in a study with any experimental drug within 30 days of commencement of the study.
No presence of gastrointestinal, renal, hepatic disease or intestinal inflammation.
Willing to comply with study diet and alcohol restrictions.</inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>80</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Use of any form of drug therapy or medication or supplements that may interfere with bowel function (such as antibiotics, laxatives etc).
Known or suspected personal history or family history of adverse events, hypersensitivity or intolerance to consumption plant-based foods which will be tested in this study.
Person considered by the investigator to be unwilling, unlikely or unable to comprehend or comply with the study protocol and restrictions.
Unwilling or unable to collect bowel motions as required.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>numbered containers</concealment>
    <sequence>Simple randomisation with computer software</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/06/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>32</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>CSIRO Food Futures National Research Flagship</primarysponsorname>
    <primarysponsoraddress>CSIRO Food and Nutritional Sciences
PO Box 10041
BC Adelaide
SA 5000</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>CSIRO Food Futures National Research Flagship</fundingname>
      <fundingaddress>CSIRO Food and Nutritional Sciences
PO Box 10041
BC Adelaide
SA 5000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study will assess whether new cerals made with a new variant of barley deliver digestive health benefits to consumers.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>CFNS Human Research Ethics Committee</ethicname>
      <ethicaddress>PO Box 10041
Adelaide BC
SA 5000</ethicaddress>
      <ethicapprovaldate>17/09/2010</ethicapprovaldate>
      <hrec>10/14</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Tony Bird</name>
      <address>CSIRO Food and Nutritional Sciences
PO Box 10041
Adelaide BC
SA 5000</address>
      <phone>+61 8 8303 8902</phone>
      <fax>+61 8 8303 8899</fax>
      <email>tony.bird@csiro.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Tony Bird</name>
      <address>CSIRO Food and Nutritional Sciences
PO Box 10041
Adelaide BC
SA 5000</address>
      <phone>+61 8 8303 8902</phone>
      <fax>+61 8 8303 8899</fax>
      <email>tony.bird@csiro.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Bianca Benassi-Evans</name>
      <address>CSIRO Food and Nutritional Sciences
PO Box 10041
Adelaide BC
SA 5000</address>
      <phone>+61 8 8303 8982</phone>
      <fax>+61 8 8303 8899</fax>
      <email>bianca.benassi@csiro.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>